Kyowa Kirin Co.,Ltd. 4151Short Interest
No institution currently reports a short position of 0.5% or more in Kyowa Kirin Co.,Ltd. (4151). The last disclosure was on 2026-10-26 (Citigroup Global Markets Limited, 0.46%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
154 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-04-03 |
|---|---|
| Latest disclosure | 2026-10-26 (Citigroup Global Markets Limited, 0.46%) |
| Reporting institutions | 8 firms (154 reports) |
| Peak estimated short interest | 1.86% (2020-10-01, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- JPM Securities Japan Co Ltd.
- Citigroup Global Markets Limited
- MERRILL LYNCH INTERNATIONAL
- Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
- BNP Paribas Arbitrage SNC
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-10-09 | JPM Securities Japan Co Ltd. | Position 2,545,266 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-10-02 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,478,332 shares | Ratio 0.47% | ▼0.22% | Below 0.5% |
| 2026-10-26 | Citigroup Global Markets Limited | Position 2,465,854 shares | Ratio 0.46% | ▼0.08% | Below 0.5% |
| 2020-10-07 | Credit Suisse Securities (Japan) Limited | Position 2,259,700 shares | Ratio 0.41% | ▼0.33% | Below 0.5% |
| 2026-01-14 | MERRILL LYNCH INTERNATIONAL | Position 2,018,812 shares | Ratio 0.38% | ▼0.15% | Below 0.5% |
| 2026-04-10 | J.P. MORGAN SECURITIES PLC | Position 729,318 shares | Ratio 0.13% | ▼0.39% | Below 0.5% |
| 2023-04-11 | BNP Paribas Arbitrage SNC | Position 0 shares | Ratio 0.00% | ▼0.63% | Closed |
| 2025-12-16 | GOLDMAN SACHS INTERNATIONAL | Position 0 shares | Ratio 0.00% | ▼0.61% | Closed |
Disclosure History 154 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-26 | Citigroup Global Markets Limited | Position 2,465,854 shares | Ratio 0.46% | ▼0.08% | Below 0.5% |
| 2026-10-20 | Citigroup Global Markets Limited | Position 2,867,454 shares | Ratio 0.54% | ▲0.09% | — |
| 2026-10-09 | JPM Securities Japan Co Ltd. | Position 2,545,266 shares | Ratio 0.48% | ▼0.09% | Below 0.5% |
| 2026-10-07 | JPM Securities Japan Co Ltd. | Position 3,032,029 shares | Ratio 0.57% | ▼0.16% | — |
| 2026-10-05 | JPM Securities Japan Co Ltd. | Position 3,846,288 shares | Ratio 0.73% | ▼0.15% | — |
| 2026-10-02 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 2,478,332 shares | Ratio 0.47% | ▼0.22% | Below 0.5% |
| 2026-09-29 | JPM Securities Japan Co Ltd. | Position 4,657,210 shares | Ratio 0.88% | ▼0.11% | — |
| 2026-09-28 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 3,662,532 shares | Ratio 0.69% | ▼0.05% | — |
| 2026-09-17 | JPM Securities Japan Co Ltd. | Position 5,243,922 shares | Ratio 0.99% | ▼0.04% | — |
| 2026-09-10 | JPM Securities Japan Co Ltd. | Position 5,416,311 shares | Ratio 1.03% | ▲0.28% | — |
| 2026-09-09 | JPM Securities Japan Co Ltd. | Position 3,970,398 shares | Ratio 0.75% | ▲0.27% | — |
| 2026-09-08 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 3,920,232 shares | Ratio 0.74% | ▲0.25% | — |
| 2026-07-07 | Citigroup Global Markets Limited | Position 1,369,495 shares | Ratio 0.26% | ▼0.45% | Below 0.5% |
| 2026-07-03 | Citigroup Global Markets Limited | Position 3,757,022 shares | Ratio 0.71% | ▲0.09% | — |
| 2026-07-01 | Citigroup Global Markets Limited | Position 3,286,665 shares | Ratio 0.62% | ▼0.33% | — |
| 2026-06-25 | Citigroup Global Markets Limited | Position 5,023,047 shares | Ratio 0.95% | ▲0.50% | — |
| 2026-05-01 | Citigroup Global Markets Limited | Position 2,612,085 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2026-04-10 | J.P. MORGAN SECURITIES PLC | Position 729,318 shares | Ratio 0.13% | ▼0.39% | Below 0.5% |
| 2026-04-08 | J.P. MORGAN SECURITIES PLC | Position 2,773,618 shares | Ratio 0.52% | ▲0.44% | — |
| 2026-03-31 | Citigroup Global Markets Limited | Position 3,040,058 shares | Ratio 0.57% | ▼0.08% | — |
| 2026-03-30 | Citigroup Global Markets Limited | Position 3,464,151 shares | Ratio 0.65% | ▼0.05% | — |
| 2026-03-05 | Citigroup Global Markets Limited | Position 3,728,569 shares | Ratio 0.70% | ▲0.12% | — |
| 2026-02-27 | Citigroup Global Markets Limited | Position 3,049,669 shares | Ratio 0.58% | ▲0.09% | — |
| 2026-02-26 | Citigroup Global Markets Limited | Position 2,613,869 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-02-25 | Citigroup Global Markets Limited | Position 2,657,269 shares | Ratio 0.50% | ▼0.19% | — |
| 2026-02-20 | Citigroup Global Markets Limited | Position 3,671,169 shares | Ratio 0.69% | ▼0.09% | — |
| 2026-02-17 | Citigroup Global Markets Limited | Position 4,116,169 shares | Ratio 0.78% | ▼0.03% | — |
| 2026-02-12 | Citigroup Global Markets Limited | Position 4,259,269 shares | Ratio 0.81% | ▲0.10% | — |
| 2026-02-09 | Citigroup Global Markets Limited | Position 3,733,269 shares | Ratio 0.71% | ▲0.09% | — |
| 2026-01-27 | Citigroup Global Markets Limited | Position 3,267,869 shares | Ratio 0.62% | ▲0.03% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Heartseed Inc.219A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Shionogi & Co.,Ltd.4507 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| WAKAMOTO PHARMACEUTICAL CO.,LTD.4512 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical |